DK1737439T3 - Calciumsalte til behandlingen af psoriasis, dermatitis og skæl - Google Patents

Calciumsalte til behandlingen af psoriasis, dermatitis og skæl

Info

Publication number
DK1737439T3
DK1737439T3 DK05731707.5T DK05731707T DK1737439T3 DK 1737439 T3 DK1737439 T3 DK 1737439T3 DK 05731707 T DK05731707 T DK 05731707T DK 1737439 T3 DK1737439 T3 DK 1737439T3
Authority
DK
Denmark
Prior art keywords
dermatitis
dandruff
psoriasis
treatment
calcium salts
Prior art date
Application number
DK05731707.5T
Other languages
English (en)
Inventor
Maria Rosa Gobbi
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Application granted granted Critical
Publication of DK1737439T3 publication Critical patent/DK1737439T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK05731707.5T 2004-04-02 2005-03-31 Calciumsalte til behandlingen af psoriasis, dermatitis og skæl DK1737439T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000665A ITMI20040665A1 (it) 2004-04-02 2004-04-02 Sale di calcio per il trattamento della psoriasi e di dermatiti
PCT/EP2005/003402 WO2005097084A2 (en) 2004-04-02 2005-03-31 Calcium salts for the treatment of psoriasis, dermatitis and dandruff

Publications (1)

Publication Number Publication Date
DK1737439T3 true DK1737439T3 (da) 2011-11-14

Family

ID=34964507

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05731707.5T DK1737439T3 (da) 2004-04-02 2005-03-31 Calciumsalte til behandlingen af psoriasis, dermatitis og skæl

Country Status (10)

Country Link
EP (1) EP1737439B1 (da)
AT (1) ATE521344T1 (da)
CY (1) CY1112033T1 (da)
DK (1) DK1737439T3 (da)
ES (1) ES2369854T3 (da)
IT (1) ITMI20040665A1 (da)
PL (1) PL1737439T3 (da)
PT (1) PT1737439E (da)
SI (1) SI1737439T1 (da)
WO (1) WO2005097084A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041279A1 (it) * 2004-06-24 2004-09-24 Pharmaproducts Uk Ltd Uso di calcio trifluoroacetato per la preparazione di medicamenti ad effetto anti-angiogenetico
ITMI20041822A1 (it) * 2004-09-24 2004-12-24 Pharmaproducts Uk Ltd "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
US20120219596A1 (en) 2009-07-30 2012-08-30 Wendelin Stark Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
EP2845591A1 (en) * 2013-09-04 2015-03-11 Polichem S.A. Use of trifluoroacetic acid as keratolytic agent to treat hyperkeratotic skin lesions
CA2956050C (en) * 2014-07-31 2023-09-12 Amorphical Ltd. Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726187A1 (fr) * 1994-10-26 1996-05-03 Jean Noel Thorel Utilisation du calcium par voie topique dans le traitement local des dermatoses hyperproliferatives comme le psoriasis
MX9704775A (es) * 1994-12-21 1998-02-28 Cosmederm Technologies Formulaciones reductoras de irritacion de la piel y su uso.
ITMI20011495A1 (it) * 2001-07-12 2003-01-12 Pharmaproducts Uk Ltd Sali di calcio ad attivita' citotossica

Also Published As

Publication number Publication date
WO2005097084A2 (en) 2005-10-20
EP1737439B1 (en) 2011-08-24
SI1737439T1 (sl) 2011-10-28
PT1737439E (pt) 2011-10-21
CY1112033T1 (el) 2015-11-04
ATE521344T1 (de) 2011-09-15
WO2005097084A3 (en) 2005-12-15
ITMI20040665A1 (it) 2004-07-02
EP1737439A2 (en) 2007-01-03
ES2369854T3 (es) 2011-12-07
PL1737439T3 (pl) 2012-01-31

Similar Documents

Publication Publication Date Title
DK1737439T3 (da) Calciumsalte til behandlingen af psoriasis, dermatitis og skæl
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
WO2005097788A3 (en) Sulfonamides and uses thereof
IS2533B (is) (S)-2-N-própýlamínó-5-hýdroxýetralín sem D3-gerandefni
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
WO2005009961A3 (en) Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
WO2007084728A3 (en) 2-imino-benzimidazoles
WO2007117465A3 (en) Indazole compounds
UA100132C2 (en) Isoxazolo-pyridine derivatives
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
IL173377A0 (en) Compounds for the treatment of metabolic disorders
MX2009000001A (es) Compuestos terapeuticos.
WO2005105110A3 (en) Doxepin analogs and methods of use thereof
NO20063308L (no) Kombinasjon av flupirtin og tramadol
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
SE0402635D0 (sv) Chemical compounds
SE0200198D0 (sv) New use
DK1664044T3 (da) Monohydreret natriumsalt af S-tenatoprazol og dets anvendelse i form af en protonpumpehæmmer
NO20033273D0 (no) Anvendelse av (R)-ibuprofen-metansulfonamid og salter derav til behandlingog forhindring av avstötning av transplanterte organer
ATE413870T1 (de) Therapeutisches mittel zur behandlung von plasmazellneoplasien
SE0402636D0 (sv) Chemical compounds
MY138165A (en) Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome
TH76783B (th) สารประกอบชนิดใหม่
RU2004108548A (ru) Средство для заживления кожных ран первичным натяжением